Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Precise coordination of the S and M phases of the eukaryotic cell cycle is critical not only for normal cell division, but also for effective growth arrest under conditions of stress. When damaged, a cell must communicate signals to both the mitotic and DNA synthesis machineries so that a mitotic block is not followed by an extra S phase, or vice versa. The biochemical mechanisms regulating this coordination, termed checkpoints, have been identified in lower eukaryotes, but are largely unknown in mammalian cells. Here we show that p21 WAF1/CIP1, the prototype inhibitor of cyclin-dependent kinases (CDKs), is required for this coordination in human cells. In the absence of p21, DNA-damaged cells arrest in a G2-like state, but then undergo additional S phases without intervening normal mitoses. They thereby acquire grossly deformed, polyploid nuclei and subsequently die through apoptosis. Perhaps not by coincidence, the DNA-damaging agents that can cause S/M uncoupling are used in the clinic to kill cancer cells preferentially.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, after transiently arresting in G2, HCT-116 cells in which p21 was knocked out eventually underwent aberrant mitoses, leading to polyploidy or cell death.53,55”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [53]
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,535
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Di Leonardo, A., Linke, S. P., Clarkin, K., & Wahl, G. M. (1994) · Genes & Development · doi:10.1101/gad.8.21.2540 · Cited by 1,215
p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.
Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., & Jacks, T. (1995) · Genes & Development · doi:10.1101/gad.9.8.935 · Cited by 1,119
Self-citationGorczyca, W., GONG, J., & Darżynkiewicz, Z. (1993) · PubMed · Cited by 982
Creative blocks: cell-cycle checkpoints and feedback controls
Murray, A. W. (1992) · Nature · doi:10.1038/359599a0 · Cited by 663
A p53-Dependent Mouse Spindle Checkpoint
Cross, S. M., Sanchez, C. A., Morgan, C. A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H., & Reid, B. J. (1995) · Science · doi:10.1126/science.7871434 · Cited by 660
Ordering S phase and M phase in the cell cycle
Nurse, P. (1994) · Cell · doi:10.1016/0092-8674(94)90539-8 · Cited by 589
Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.
El‐Deiry, W. S., Tokino, T., Waldman, T. A., Oliner, J., Velculescu, V. E., Burrell, M., HILL, D. E., Healy, E., Rees, J. L., & Hamilton, S. R. (1995) · PubMed · Cited by 582
Self-citation
Research works printed but not linked: 8
- Waldman, T., Kinzler, K. W. & Vogelstein, B. Cancer Res. 55, 5187–5190 (1995).
- Gorczyca, W., Gong, J. & Darzynkiewicz, Z. Cancer Res. 53, 1945–1951 (1993).
- Gao, X. et al. Oncogene 11, 1395–1398 (1995).
- El-Deiry, W. A. et al. Cancer Res. 55, 2910–2919 (1995).
- Kung, A. L., Zetterberg, A., Sherwood, S. W. & Schimke, R. T. Cancer Res. 50, 7307–7317 (1990).
- Carder, P. et al. Oncogene 8, 1397–1401 (1993).
- Harvey, M. et al. Oncogene 8, 2457–2467 (1993).
- Morrow, C. S. & Cowan, K. H. in Cancer Medicine (eds Holland, J. F. et al.), 618–631 (Lea & Febiger, Philadelphia, 1993).
Cited by
Items 201–300 of 727
Forrester, H. B., Vidair, C. A., Albright, N., Ling, C. C., & Dewey, W. C. (1999) · PubMed · Cited by 84
Frattini, M. G., Hurst, S. D., Lim, H. B., Swaminathan, S., & Laimins, L. A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.2.318 · Cited by 95
Ohmori, T., Yang, J.-L., Price, J. O., & Arteaga, C. L. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4261 · Cited by 98
p53 and retinoblastoma pathways in bladder cancer
Mitra, A. P., Birkhahn, M., & Côté, R. J. (2007) · World Journal of Urology · doi:10.1007/s00345-007-0197-0 · Cited by 93
Iwadate, Y., Mizoe, J.-E., Osaka, Y., Yamaura, A., & Tsujii, H. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01514-0 · Cited by 87
Functional role of p21 during the cellular response to stress.
Gorospe, M., Wang, X., & Holbrook, N. J. (1999) · Europe PMC (PubMed Central) · Cited by 97
Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer.
Sjöström, J., BLOMQVIST, C. P., Heikkilä, P., von Boguslawski, K., Räisänen-Sokolowski, A. K., Bengtsson, N. O., Mjaaland, I., Malmström, P., Ostenstadt, B., Bergh, J. C. S., et al. (2000) · PubMed · Cited by 83
Genetic and Molecular Markers of Urothelial Premalignancy and Malignancy
Cordon‐Cardo, C., Côté, R. J., & Sauter, G. (2000) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/003655900750169338 · Cited by 83
Molecular Aspects of Bladder Cancer
Kausch, I., & Andreas Böhle, E. (2002) · European Urology · doi:10.1016/s0302-2838(01)00007-0 · Cited by 80
Restoring p53-mediated apoptosis in cancer cells: New opportunities for cancer therapy
Yu, Q. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2006.03.001 · Cited by 87
Yang, C., Patten, C. W.-V., Planchon, S. M., Wuerzberger‐Davis, S. M., Davis, T. W., Cuthill, S., Miyamoto, S., & Boothman, D. A. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.2.379 · Cited by 80
Mammalian runt-domain proteins and their roles in hematopoiesis, osteogenesis, and leukemia
Westendorf, J. J., & Hiebert, S. W. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1999)75:32+<51::aid-jcb7>3.0.co;2-s · Cited by 133
The Transcriptional Repressor hDaxx Potentiates p53-dependent Apoptosis
Gostissa, M., Morelli, M., Mantovani, F., Guida, E., Piazza, S., Collavin, L., Brancolini, C., Schneider, C., & Del Sal, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310801200 · Cited by 79
p21Waf1/Cip1/Sdi1 mediates retinoblastoma protein degradation
Broude, E. V., Swift, M. E., Vivo, C., Chang, B.-D., Davis, B. M., Kalurupalle, S., Blagosklonny, M. V., & Roninson, I. B. (2007) · Oncogene · doi:10.1038/sj.onc.1210516 · Cited by 94
Gewirtz, D. A. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006414422919 · Cited by 85
Inhibition of Chk1 Kills Tetraploid Tumor Cells through a p53-Dependent Pathway
Vitale, I., Galluzzi, L., Vivet, S., Nanty, L., Dessen, P., Senovilla, L., Olaussen, K. A., Lazar, V., Prudhomme, M., Golsteyn, R. M., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001337 · Cited by 77
“proteins p21 [14], Bax [8], APC [15], or Lats2 [12] facilitates the generation of tetraploid cells.”
BackgroundAaltomaa, S. H., Eskelinen, M. J., & Lipponen, P. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990215)38:3<183::aid-pros2>3.0.co;2-w · Cited by 80
Overexpression of c-Myc Alters G 1 /S Arrest following Ionizing Radiation
Sheen, J.-H., & Dickson, R. B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1819-1833.2002 · Cited by 76
Jennings, L. D., Kincaid, S. L., Wang, Y. D., Krishnamurthy, G., Beyer, C. F., McGinnis, J. P., Miranda, M., Discafani, C. M., & Rabindran, S. K. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.07.072 · Cited by 75
McKenzie, P., Guichard, S. M., Middlemas, D. S., Ashmun, R. A., Danks, M. K., & Harris, L. C. (1999) · PubMed · Cited by 85
Role of apoptotic response in cellular resistance to cytotoxic agents
Zunino, F., Perego, P., Pilotti, S., Pratesi, G., Supino, R., & Arcamone, F. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)00086-7 · Cited by 83
Lodygin, D., Menssen, A., & Hermeking, H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16588 · Cited by 74
del Muro, X. G., Condom, E., Vigués, F., Castellsagué, X., Figueras, A., Muñoz, J., Solà, J., Soler, T., Capellá, G., & Germà, J. R. (2004) · Cancer · doi:10.1002/cncr.20200 · Cited by 80
Chromosomal breaks during mitotic catastrophe trigger γH2AX–ATM–p53-mediated apoptosis
Imreh, G., Norberg, H. V., Imreh, S., & Zhivotovsky, B. (2011) · Journal of Cell Science · doi:10.1242/jcs.081612 · Cited by 78
Human p14ARF-mediated cell cycle arrest strictly depends on intact p53 signaling pathways
Weber, H. O., Samuel, T., Rauch, P., & Funk, J. O. (2002) · Oncogene · doi:10.1038/sj.onc.1205429 · Cited by 85
p27 in Cell Cycle Control and Cancer
Møller, M. B. (2000) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190009053535 · Cited by 87
Wiebusch, L., & Hagemeier, C. (2010) · Oncogene · doi:10.1038/onc.2010.99 · Cited by 82
Vigneron, A., Cherier, J., Barré, B., Gamelin, E., & Coqueret, O. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602492200 · Cited by 73
The molecular control of DNA damage-induced cell death
Coultas, L., & Strasser, A. (2000) · APOPTOSIS · doi:10.1023/a:1009617727938 · Cited by 77
Miyazaki, T., & Arai, S. (2007) · Cell Cycle · doi:10.4161/cc.6.12.4409 · Cited by 71
Investigations of methylmercury-induced alterations in neurogenesis.
Faustman, E. M., Ponce, R. A., Ou, Y. C., Mendoza, M. A. C., Lewandowski, T. A., & Kavanagh, T. J. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.02110s5859 · Cited by 73
Upadhyay, S. K., Neburi, M., Chinni, S. R., Alhasan, S., Miller, F. W., & Sarkar, F. H. (2001) · PubMed · Cited by 72
Spierings, D. C. J., de Vries, E. G. E., Vellenga, E., & de Jong, S. (2003) · The Journal of Pathology · doi:10.1002/path.1373 · Cited by 72
Effects of p 53 mutations on apoptosis in mouse intestinal and human colonic adenomas
Fazeli, A., Steen, R. G., Dickinson, S., Bautista, D., Dietrich, W. F., Bronson, R. T., Bresalier, R. S., Lander, E. S., Costa, J. C., & Weinberg, R. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10199 · Cited by 82
Wendt, J., Radetzki, S., von Haefen, C., Hemmati, P., Güner, D., Schulze‐Osthoff, K., Dörken, B., & Daniel, P. T. (2005) · Oncogene · doi:10.1038/sj.onc.1209031 · Cited by 71
Chiang, C.-T., Way, T., & Lin, J. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0107 · Cited by 71
Differential regulation of p21 by p53 and Rb in cellular response to oxidative stress
Yin, Y., Solomon, G., Deng, C., & Barrett, J. C. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199901)24:1<15::aid-mc3>3.0.co;2-y · Cited by 71
Cell Cycle-Dependent Phosphorylation of p27 Cyclin-Dependent Kinase (Cdk) Inhibitor by Cyclin E/Cdk2
Morisaki, H., Fujimoto, A., Ando, A., Nagata, Y., Ikeda, K., & Nakanishi, M. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7590 · Cited by 69
Repression of BRCA1 through a Feedback Loop Involving p53
MacLachlan, T. K., Dash, B. C., Dicker, D. T., & El-Deiry, W. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003338200 · Cited by 70
Prognostic Value of Cell-Cycle Regulation Biomarkers in Bladder Cancer
Mitra, A. P., Hansel, D. E., & Côté, R. J. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.08.008 · Cited by 76
Immunomodulatory effects of tumor-associated fibroblasts in colorectal-tumor development
Lieubeau, B., Heymann, M., Henry, F., Barbieux, I., Méflah, K., & Gr�goire, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990517)81:4<616::aid-ijc18>3.0.co;2-s · Cited by 85
DNA Damage Triggers p21WAF1-dependent Emi1 Down-Regulation That Maintains G2 Arrest
Lee, J., Kim, J. A., Barbier, V., Fotedar, A., & Fotedar, R. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-08-0818 · Cited by 68
“HCT116 (parental and isogenic p21 / ; parental and isogenic p53 / ) are near diploid colorectal carcinoma cells and were kindly provided by Bert Vogelstein (Johns Hopkins University, Baltimore, MD) (Waldman et al., 1996; Bunz et al., 1998).”
BackgroundMethodInfluentialp21 stability: Linking chaperones to a cell cycle checkpoint
Liu, G., & Lozano, G. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.019 · Cited by 68
Differentiation-Related Changes in the Cell Cycle Traverse
Studzinski, G. P., & Harrison, L. E. (1999) · International review of cytology · doi:10.1016/s0074-7696(08)61384-4 · Cited by 76
Nuclear Envelope Irregularity Is Induced by RET/PTC During Interphase
Fischer, A. H., Taysavang, P., & Jhiang, S. M. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63468-2 · Cited by 67
Yamamoto, H., Soh, J., Shirin, H., Xing, W.-Q., Lim, J. T., Yao, Y., Slosberg, E. D., Tomita, N., Schieren, I., & Weinstein, I. B. (1999) · Oncogene · doi:10.1038/sj.onc.1202269 · Cited by 73
Endlich, B., Radford, I. R., Forrester, H. B., & Dewey, W. C. (2000) · Radiation Research · doi:10.1667/0033-7587(2000)153[0036:cvtlms]2.0.co;2 · Cited by 66
“In accord with the presence of mutant TP53, Inanami et al. (29) reported that CDKN1A (formerly known as p21WAF1/CIP1), believed to be an effector of cell cycle delay dependent on and downstream of TP53, was not induced by irradiation of MOLT-4 cells.”
BackgroundInfluentialRbm24, an RNA-binding Protein and a Target of p53, Regulates p21 Expression via mRNA Stability
Jiang, Y., Zhang, M., Qian, Y., Xu, E., Zhang, J., & Chen, X. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.524413 · Cited by 67
Rho regulates p21CIP1, cyclin D1, and checkpoint control in mammary epithelial cells
Liberto, M., Cobrinik, D. E., & Minden, A. (2002) · Oncogene · doi:10.1038/sj.onc.1205242 · Cited by 68
Distinct roles for p53, p27Kip1, and p21Cip1 during tumor development
Staheli, J. P., Kim, K.-H., Liggitt, D., Gurley, K. E., Longton, G., & Kemp, C. J. (2003) · Oncogene · doi:10.1038/sj.onc.1207220 · Cited by 72
Abdel-Fatah, T. M. A., Powe, D. G., Agboola, J., Adamowicz‐Brice, M., Blamey, R. W., López‐García, M. Á., Green, A. R., Reis-Filho, J. S., & Ellis, I. O. (2009) · The Journal of Pathology · doi:10.1002/path.2663 · Cited by 67
Bhat (2009) · International Journal of Oncology · doi:10.3892/ijo_00000185 · Cited by 68
Gopalsamy, A., Yang, H., Ellingboe, J. W., Tsou, H., Zhang, N., Honores, E. E., Powell, D. W., Miranda, M., McGinnis, J. P., & Rabindran, S. K. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.01.066 · Cited by 65
Shin, S. Y., Kim, C. G., Kim, S. H., Kim, Y. S., Lim, Y., & Lee, Y. H. (2010) · Experimental & Molecular Medicine · doi:10.3858/emm.2010.42.5.041 · Cited by 70
Héliez, C., Baricault, L., Barboule, N., & Valette, A. (2003) · Oncogene · doi:10.1038/sj.onc.1206409 · Cited by 64
Radiation-Induced Caspase-8 Mediates p53-Independent Apoptosis in Glioma Cells
Afshar, G., Jelluma, N., Yang, X., Basila, D., Arvold, N. D., Karlsson, A., Yount, G. L., Dansen, T. B., Koller, E., & Haas-Kogan, D. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1283 · Cited by 71
AMF1 (GPS2) Modulates p53 Transactivation
Peng, Y., Kuo, F., Breiding, D. E., Wang, Y., Mansur, C. P., & Androphy, E. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5913-5924.2001 · Cited by 64
Methotrexate increases expression of cell cycle checkpoint genes via JNK activation
Spurlock, C. F., Tossberg, J. T., Fuchs, H. A., Olsen, N. J., & Aune, T. M. (2011) · Arthritis & Rheumatism · doi:10.1002/art.34342 · Cited by 62
Idogawa, M., Sasaki, Y., Suzuki, H., Mita, H., Imai, K., Shinomura, Y., & Tokino, T. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2396 · Cited by 65
Wendt, J., von Haefen, C., Hemmati, P., Belka, C., Dörken, B., & Daniel, P. T. (2005) · Oncogene · doi:10.1038/sj.onc.1208580 · Cited by 64
Vrana, J. A., Saunders, A. M., Chellappan, S., & Grant, S. (1998) · Differentiation · doi:10.1046/j.1432-0436.1998.6310033.x · Cited by 68
Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
Bearss, D. J., Lee, R. J., Troyer, D. A., Pestell, R. G., & Windle, J. J. (2002) · PubMed · Cited by 77
Cell Cycle Regulation of DNA Replication: The Endoreduplication Perspective
Grafi, G. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4213 · Cited by 69
Helmbold, H., Komm, N., Deppert, W., & Bohn, W. (2009) · Oncogene · doi:10.1038/onc.2009.222 · Cited by 68
Vigneron, A., Roninson, I. B., Gamelin, E., & Coqueret, O. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0461 · Cited by 61
Song, Y. W., Lim, Y., & Cho, S. K. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.02.003 · Cited by 68
Reduction of UV-induced Cell Death in the Human Senescent Fibroblasts
Yeo, E.-J., Hwang, Y.-C., Kang, C.-M., Choy, H. E., & Park, S. C. (2000) · Molecules and Cells · doi:10.1016/s1016-8478(23)17496-6 · Cited by 61
Mueller, S., Cadenas, E., & Schönthal, A. H. (2000) · PubMed · Cited by 72
Inhibition of cdk2 Activating Phosphorylation by Mevastatin
Ukomadu, C., & Dutta, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208658200 · Cited by 65
The fate of E- and P-cadherin during the early stages of apoptosis
Schmeiser, K., & Grand, R. J. A. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400504 · Cited by 61
Vogelstein, B., & Kinzler, K. W. (2001) · Nature · doi:10.1038/35091170 · Cited by 77
Self-citationRibosomal Protein S27-like, a p53-Inducible Modulator of Cell Fate in Response to Genotoxic Stress
Li, J., Tan, J. Y., Li, Z., Banerjee, B., Yang, X., Chau, J. F. L., Lee, P. L., Hande, M. P., Li, B., & Yu, Q. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1088 · Cited by 60
Inoue, H., Hwang, S. H., Wecksler, A. T., Hammock, B. D., & Weiss, R. H. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.9.17680 · Cited by 59
Transcriptional Regulation of Mitotic Checkpoint Gene MAD1 by p53
Chun, A. C. S., & Jin, D.-Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307185200 · Cited by 60
Wang, C.-C., Liao, Y.-P., Mischel, P. S., Iwamoto, K. S., Cacalano, N. A., & McBride, W. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0185 · Cited by 60
Liu, J.-D., Wang, Y., Chen, C.-H., Yu, C.-F., Chen, L.-C., Lin, J.-K., Liang, Y., Lin, S.-Y., & Ho, Y. (2003) · Molecular Carcinogenesis · doi:10.1002/mc.10118 · Cited by 59
IFN-gamma Induction of p21WAF1 Is Required for Cell Cycle Inhibition and Suppression of Apoptosis
Hobeika, A. C., Etienne, W., Torres, B. A., Johnson, H. M., & Subramaniam, P. S. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099312812 · Cited by 59
The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage
Salomoni, P., Bernardi, R., Bergmann, S., Changou, A., Tuttle, S. L., & Pandolfi, P. P. (2004) · Blood · doi:10.1182/blood-2004-09-3782 · Cited by 58
Tortora, G., Caputo, R., Damiano, V., Bianco, R., Pepe, S., Bianco, A. R., Jiang, Z., Agrawal, S., & Ciardiello, F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12586 · Cited by 60
Bouhaddou, M., Barrette, A. M., Stern, A. D., Koch, R. J., DiStefano, M. S., Riesel, E. A., Santos, L. C., Tan, A. L., Mertz, A. E., & Birtwistle, M. R. (2018) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005985 · Cited by 58
p53 dependent and independent sensitivity to oxaliplatin of colon cancer cells
Toscano, F., Parmentier, B., Fajoui, Z. E., Estornes, Y., Chayvialle, J., Saurin, J., & Abello, J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.05.001 · Cited by 72
de Carné Trécesson, S., Guillemin, Y., Bélanger, A., Bernard, A.-C., Preisser, L., Ravon, E., Gamelin, E., Juin, P., Barré, B., & Coqueret, O. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.186437 · Cited by 57
Gibbs, E., Kelman, Z., Gulbis, J. M., O'Donnell, M., Kuriyan, J., Burgers, P. J., & Hurwitz, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2373 · Cited by 58
Induction of p21WAF/CIP1 during Hyperoxia
McGrath, S. A. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.18.2.2964m · Cited by 58
TBX2 and TBX3: The special value for anticancer drug targets
Lu, J., Li, X.-P., Dong, Q., Kung, H.-F., & He, M.-L. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.07.001 · Cited by 57
“In primary cells, this pathway can act as a monitor of oncogenic transformation and can induce p53-dependent or -independent cell cycle arrest, senescence and apoptosis.”
Kim, W., Kook, S., Kim, D. J., Teodorof, C., & Song, W. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312026200 · Cited by 57
p21CIP1 Is Dispensable for the G2 Arrest Caused by Genistein in Human Melanoma Cells
Casagrande, F., & Darbon, J.-M. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4914 · Cited by 63
Litwiniec, A., Gackowska, L., Helmin-Basa, A., Żuryń, A., & Grzanka, A. (2013) · Cancer Cell International · doi:10.1186/1475-2867-13-9 · Cited by 55
Sinicrope, F. A., Roddey, G., Lemoine, M., Ruan, S., Stephens, L. C., Frazier, M. L., Shen, Y., & Zhang, W. (1998) · PubMed · Cited by 56
Disruption of the Pelota Gene Causes Early Embryonic Lethality and Defects in Cell Cycle Progression
Adham, I. M., Sallam, M. A., Steding, G., Korabiowska, M., Brinck, U., Hoyer‐Fender, S., Oh, C., & Engel, W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.4.1470-1476.2003 · Cited by 68
Inactivation of p21 by E1A Leads to the Induction of Apoptosis in DNA-Damaged Cells
Chattopadhyay, D., Ghosh, M. K., Mal, A. K., & Harter, M. L. (2001) · Journal of Virology · doi:10.1128/jvi.75.20.9844-9856.2001 · Cited by 65
p21: structure and functions associated with cyclin-CDK binding
Ball, K. L. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7_10 · Cited by 62
Jonchère, B., Vétillard, A., Toutain, B., Lam, D., Bernard, A. C., Henry, C., Trécesson, S. D. C., Gamelin, E., Juin, P., Guette, C., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2774 · Cited by 55
Cell cycle regulating proteins p21 and p27 in prognosis of oral squamous cell carcinomas
Fillies, T., Woltering, M., Brandt, B., Diest, J.-P. V., Werkmeister, R., Joos, U., & Buerger, H. (2007) · Oncology Reports · doi:10.3892/or.17.2.355 · Cited by 55
The therapeutic potential of targeting the cell cycle
Webster, K. R. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.6.865 · Cited by 60
Genetic Analysis of Mammalian Cyclin-Dependent Kinases and Their Inhibitors
Malumbres, M., Ortega, S., & Barbacid, M. (2000) · Biological Chemistry · doi:10.1515/bc.2000.105 · Cited by 55
Defective control of apoptosis, radiosensitivity, and spindle checkpoint in ataxia telangiectasia.
Takagi, M., Delia, D., Chessa, L., Iwata, S., Shigeta, T., Kanke, Y., Goi, K., Asada, M., Eguchi, M., Kodama, C., et al. (1998) · PubMed · Cited by 63
Effect of p21waf1/cip1 transgene on radiation induced apoptosis in T cells
Fotedar, R., Brickner, H., Saadatmandi, N., Rousselle, T., Diederich, L., Munshi, A., Jung, B. H., Reed, J. C., & Fotedar, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202693 · Cited by 67
GLUT-1 expression in ovarian carcinoma: Association with survival and response to chemotherapy
Cantuaria, G., Fagotti, A., Ferrandina, G., Magalhaes, A., Nadji, M., Angioli, R., Penalver, M., Mancuso, S., & Scambia, G. (2001) · Cancer · doi:10.1002/1097-0142(20010901)92:5<1144::aid-cncr1432>3.0.co;2-t · Cited by 166
Núñez, F., Chipchase, M. D., Clarke, A. R., & Melton, D. W. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.9.1073 · Cited by 54
Metadata
- Authors
- Waldman, T., Lengauer, C., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Nature
- Published
- 1996-06
- Volume
- 381
- Issue
- 6584
- Pages
- 713-716
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2008117987
- Cited by
- 728
- References
- 28
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 2 · 2023: 10 · 2022: 1 · 2021: 6 · 2020: 6 · 2019: 4 · 2018: 12 · 2017: 5 · 2016: 11 · 2015: 5 · 2014: 8 · 2013: 10 · 2012: 18
- FWCI
- 32.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- p21, cell cycle checkpoints, cyclin-dependent kinases, DNA damage response, polyploidy, apoptosis, anticancer agents, cell cycle coordination
- MeSH terms
- Antineoplastic Agents, Camptothecin, DNA Damage, Doxorubicin, Enzyme Inhibitors, Etoposide, Fluorescent Dyes, Gamma Rays, Bisbenzimidazole, Humans, Mitosis, Tumor Cells, Cultured, S Phase, Cyclins, Apoptosis, Cyclin-Dependent Kinases, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.